版本:
中国

BRIEF-US Patent board rules for Biogen in Forward patent case

March 31 Forward Pharma A/S

* US Patent Trial and Appeal Board ruling is about "interference" and follows earlier ruling for biogen on ipr Further company coverage: (Reporting By Caroline Humer)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐